Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Management of leptomeningeal metastases: Prognostic factors and associated outcomes.

Brower JV, Saha S, Rosenberg SA, Hullett CR, Ian Robins H.

J Clin Neurosci. 2016 Jan 8. pii: S0967-5868(15)00625-6. doi: 10.1016/j.jocn.2015.11.012. [Epub ahead of print]

PMID:
26778048
2.

Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.

Brower JV, Forman JD, Kupelian PA, Petereit DG, Gondi V, Lawton CA, Anger N, Saha S, Chappell R, Ritter MA.

Radiother Oncol. 2016 Jan 2. pii: S0167-8140(15)00679-9. doi: 10.1016/j.radonc.2015.12.018. [Epub ahead of print]

PMID:
26755165
3.

Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver.

Wojcieszynski AP, Rosenberg SA, Brower JV, Hullett CR, Geurts MW, Labby ZE, Hill PM, Bayliss RA, Paliwal B, Bayouth JE, Harari PM, Bassetti MF.

Radiother Oncol. 2015 Nov 25. pii: S0167-8140(15)00573-3. doi: 10.1016/j.radonc.2015.10.024. [Epub ahead of print]

PMID:
26627702
4.

Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension.

Wall M, Falardeau J, Fletcher WA, Granadier RJ, Lam BL, Longmuir RA, Patel AD, Bruce BB, He H, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group.

Neurology. 2015 Sep 1;85(9):799-805. doi: 10.1212/WNL.0000000000001896. Epub 2015 Aug 5.

PMID:
26245929
5.

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.

Ghebremariam YT, Cooke JP, Gerhart W, Griego C, Brower JB, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD.

J Transl Med. 2015 Aug 1;13:249. doi: 10.1186/s12967-015-0614-x.

6.

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.

Liu E, Schmidt ME, Margolin R, Sperling R, Koeppe R, Mason NS, Klunk WE, Mathis CA, Salloway S, Fox NC, Hill DL, Les AS, Collins P, Gregg KM, Di J, Lu Y, Tudor IC, Wyman BT, Booth K, Broome S, Yuen E, Grundman M, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

Neurology. 2015 Aug 25;85(8):692-700. doi: 10.1212/WNL.0000000000001877. Epub 2015 Jul 24.

PMID:
26208959
7.

Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2015 Sep;122(9):1846-53.e5. doi: 10.1016/j.ophtha.2015.05.042. Epub 2015 Jul 2.

PMID:
26143666
8.

Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience.

Liang E, Brower JV, Rice SR, Buehler DG, Saha S, Kimple RJ.

PLoS One. 2015 Jun 8;10(6):e0129476. doi: 10.1371/journal.pone.0129476. eCollection 2015.

9.

Inflammatory and Vasoactive Effects of Serum Following Inhalation of Varied Complex Mixtures.

Aragon MJ, Chrobak I, Brower J, Roldan L, Fredenburgh LE, McDonald JD, Campen MJ.

Cardiovasc Toxicol. 2015 Apr 22. [Epub ahead of print]

PMID:
25900702
10.

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.

Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, Stevens EM, Maxwell KN, Kulkarni A, Chavez T, Brandt A, Long JM, Powers J, Stopfer JE, Nathanson KL, Domchek SM.

Genet Med. 2016 Jan;18(1):25-33. doi: 10.1038/gim.2015.19. Epub 2015 Apr 2.

PMID:
25834950
11.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW.

N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18.

12.

Evaluation of the Intermittent Exotropia Questionnaire using Rasch analysis.

Leske DA, Holmes JM, Melia BM; Pediatric Eye Disease Investigator Group.

JAMA Ophthalmol. 2015 Apr;133(4):461-5. doi: 10.1001/jamaophthalmol.2014.5622.

PMID:
25634146
13.

Proton therapy and helical tomotherapy result in reduced dose deposition to the pancreas in the setting of cranio-spinal irradiation for medulloblastoma: implications for reduced risk of diabetes mellitus in long-term survivors.

Brower JV, Gans S, Hartsell WF, Goldman S, Fangusaro JR, Patel N, Lulla RR, Smiley NP, Chang JH, Gondi V.

Acta Oncol. 2015 Apr;54(4):563-6. doi: 10.3109/0284186X.2014.978368. Epub 2014 Nov 20. No abstract available.

PMID:
25410591
14.

Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).

Altaweel MM, Daniel E, Martin DF, Mittra RA, Grunwald JE, Lai MM, Melamud A, Morse LS, Huang J, Ferris FL 3rd, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Comparison of Age-related Macular Degeneration Treatments Trials CATT Research Group.

Ophthalmology. 2015 Feb;122(2):391-398.e5. doi: 10.1016/j.ophtha.2014.08.020. Epub 2014 Oct 11.

15.

The National Environmental Respiratory Center (NERC) experiment in multi-pollutant air quality health research: IV. Vascular effects of repeated inhalation exposure to a mixture of five inorganic gases.

Mauderly JL, Kracko D, Brower J, Doyle-Eisele M, McDonald JD, Lund AK, Seilkop SK.

Inhal Toxicol. 2014 Sep;26(11):691-6. doi: 10.3109/08958378.2014.947448.

PMID:
25162721
16.

Adenine nucleotide translocase 4 is expressed within embryonic ovaries and dispensable during oogenesis.

Lim CH, Brower JV, Resnick JL, Oh SP, Terada N.

Reprod Sci. 2015 Feb;22(2):250-7. doi: 10.1177/1933719114542026. Epub 2014 Jul 16.

17.

MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells.

Brower JV, Clark PA, Lyon W, Kuo JS.

Neurochem Int. 2014 Nov;77:68-77. doi: 10.1016/j.neuint.2014.06.002. Epub 2014 Jun 14. Review.

18.

Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials.

Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2014 Oct;121(10):1956-65. doi: 10.1016/j.ophtha.2014.04.020. Epub 2014 May 15.

19.

Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Repka MX, Kraker RT, Holmes JM, Summers AI, Glaser SR, Barnhardt CN, Tien DR; Pediatric Eye Disease Investigator Group.

JAMA Ophthalmol. 2014 Jul;132(7):799-805. doi: 10.1001/jamaophthalmol.2014.392.

20.

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ.

JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk